Netherlands Focus The company operates primarily in The Netherlands with a focus on life sciences consulting for pharma, biotech and healthcare, presenting an opportunity to upsell local GMP readiness, QA/QC improvements, and CMC/MSAT support for emerging Dutch projects.

Small to Mid-Size Headcount 51-200 and revenue under 1M USD indicate a growth phase and potential need for scalable CQV, quality systems, and project acceleration services as they take on larger, more complex programs.

Full Compliance Suite Offerings span engineering, CQV, CMC/MSAT, and QA/QC, suggesting cross-selling to clients pursuing end-to-end regulatory readiness and manufacturing scale-up, especially for GMP-ready transitions.

Collaborative Flexibility Emphasize practical, high-value, multidisciplinary support with fast execution, aligning with a sales angle that positions the firm as a flexible partner for fast-moving drug development and manufacturing milestones.

Digital & Partnerships Current tech stack and marketing intake signals readiness for targeted outreach; leverage LinkedIn Ads and SEO posture to reach Dutch pharma, biotech startups, and scale-ups seeking external expertise to mitigate compliance risk and accelerate timelines.